Wednesday, March 10, 2010

Seroquel Trial Update :: Drug Recall Lawyer Blog

Seroquel%20Logo%20%2803-10-10%29.gifThe New Jersey Superior Court Case (Middlesex County) of Baker v. AstraZeneca Pharmaceuticals LP is now focusing on the drug manufacturer’s advertising strategy. The plaintiff in that case is alleging that he should have been better warned about the risks for weight gain and developing diabetes.

On the plaintiff’s side is Dr. Wayne Geller, a former AstraZeneca employee—a global safety officer—who testified that the company rebuffed his efforts to strengthen internal documents describing the weight gain issue. He testified that “I found out there were people from the commercial side” who opposed the changes. This is another indication of marketing trumping. AstraZeneca is defending the case, noting that it adequately warned about the risk of diabetes, and that Seroquel doesn’t cause diabetes, anyway. They rely on several studies that showed favorable data, but other reports show average weight gain for users on Seroquel is 27 pounds.

And finally, AstraZeneca has taken a hit in the U.K., where the Prescription Medicines Code of Practice Authority decided that AstraZeneca unethically failed to accurately describe the side effects of Seroquel in a British Journal of Psychiatry advertisement in 2004.

Posted via web from Jack's posterous

No comments: